These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 36468302)
21. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R. Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864 [TBL] [Abstract][Full Text] [Related]
22. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes. Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967 [TBL] [Abstract][Full Text] [Related]
25. Epigalloccatechin-3-gallate inhibits ocular neovascularization and vascular permeability in human retinal pigment epithelial and human retinal microvascular endothelial cells via suppression of MMP-9 and VEGF activation. Lee HS; Jun JH; Jung EH; Koo BA; Kim YS Molecules; 2014 Aug; 19(8):12150-72. PubMed ID: 25123184 [TBL] [Abstract][Full Text] [Related]
26. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy. Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996 [TBL] [Abstract][Full Text] [Related]
27. Retinal not systemic oxidative and inflammatory stress correlated with VEGF expression in rodent models of insulin resistance and diabetes. Mima A; Qi W; Hiraoka-Yamomoto J; Park K; Matsumoto M; Kitada M; Li Q; Mizutani K; Yu E; Shimada T; Lee J; Shoelson SE; Jobin C; Rask-Madsen C; King GL Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8424-32. PubMed ID: 23197686 [TBL] [Abstract][Full Text] [Related]
28. Vascular permeability in retinopathy is regulated by VEGFR2 Y949 signaling to VE-cadherin. Smith RO; Ninchoji T; Gordon E; André H; Dejana E; Vestweber D; Kvanta A; Claesson-Welsh L Elife; 2020 Apr; 9():. PubMed ID: 32312382 [TBL] [Abstract][Full Text] [Related]
29. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy. Kim JH; Kim JH; Yu YS; Cho CS; Kim KW J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135 [TBL] [Abstract][Full Text] [Related]
30. Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy. Behl T; Kotwani A Pharmacol Res; 2015 Sep; 99():137-48. PubMed ID: 26054568 [TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188 [TBL] [Abstract][Full Text] [Related]
33. Regulation of human feto-placental endothelial barrier integrity by vascular endothelial growth factors: competitive interplay between VEGF-A Pang V; Bates DO; Leach L Clin Sci (Lond); 2017 Dec; 131(23):2763-2775. PubMed ID: 29054861 [TBL] [Abstract][Full Text] [Related]
34. VEGF164 is proinflammatory in the diabetic retina. Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656 [TBL] [Abstract][Full Text] [Related]
35. [Effect of retinal coagulation status on oxidative metabolite and VEGF in 208 patients with proliferative diabetic retinopathy]. Augustin AJ; Keller A; Koch F; Jurklies B; Dick B Klin Monbl Augenheilkd; 2001 Feb; 218(2):89-94. PubMed ID: 11258131 [TBL] [Abstract][Full Text] [Related]
36. Methylglyoxal-induced imbalance in the ratio of vascular endothelial growth factor to angiopoietin 2 secreted by retinal pigment epithelial cells leads to endothelial dysfunction. Bento CF; Fernandes R; Matafome P; Sena C; Seiça R; Pereira P Exp Physiol; 2010 Sep; 95(9):955-70. PubMed ID: 20562294 [TBL] [Abstract][Full Text] [Related]
37. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis. Mei X; Zhou L; Zhang T; Lu B; Sheng Y; Ji L Vascul Pharmacol; 2018 Feb; 101():29-37. PubMed ID: 29146180 [TBL] [Abstract][Full Text] [Related]
38. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Pe'er J; Shweiki D; Itin A; Hemo I; Gnessin H; Keshet E Lab Invest; 1995 Jun; 72(6):638-45. PubMed ID: 7540233 [TBL] [Abstract][Full Text] [Related]
39. Effects of an Aquaporin 4 Inhibitor, TGN-020, on Murine Diabetic Retina. Oosuka S; Kida T; Oku H; Horie T; Morishita S; Fukumoto M; Sato T; Ikeda T Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230876 [TBL] [Abstract][Full Text] [Related]
40. The augmentation of O-GlcNAcylation reduces glyoxal-induced cell injury by attenuating oxidative stress in human retinal microvascular endothelial cells. Liu GD; Xu C; Feng L; Wang F Int J Mol Med; 2015 Oct; 36(4):1019-27. PubMed ID: 26311324 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]